We thank the readers for their interest in our recent article and agree with the suggestions
provided throughout our article.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Archives of Physical Medicine and RehabilitationAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Noninvasive brain stimulation: challenges and opportunities for a new clinical specialty.J Neuropsychiatry Clin Neurosci. 2018; 30: 173-179
- Effects of non-invasive brain stimulation on freezing of gait in parkinsonism: a systematic review with meta-analysis.Parkinsonism Relat Disord. 2019; 64: 82-89
- Noninvasive brain stimulation combined with other therapies improves gait speed after stroke: a systematic review and meta-analysis.Top Stroke Rehabil. 2019; 26: 201-213
- The role of repetitive transcranial magnetic stimulation (rTMS) in the treatment of cognitive impairment in patients with Alzheimer's disease: a systematic review and meta-analysis.J Neurol Sci. 2019; 398: 184-191
- Therapeutic noninvasive brain stimulation in Alzheimer's disease.Curr Alzheimer Res. 2017; 14: 362-376
Article info
Footnotes
Disclosures: none.
Identification
Copyright
© 2020 Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation Medicine
ScienceDirect
Access this article on ScienceDirectLinked Article
- Optimizing Noninvasive Stimulation to Treat Gait Problems in Parkinson DiseaseArchives of Physical Medicine and RehabilitationVol. 101Issue 6
- PreviewWe read with great interest the study from Xie et al1 on the effects of repetitive transcranial magnetic stimulation (rTMS) on gait and freezing of gait (FoG) in Parkinson disease (PD). The authors showed that rTMS can reduce the walking performance in individuals with PD during the short-term, but has no major effect in the long-term. Additionally, the difference between rTMS and no intervention in the scores of the FoG and timed Up and Go test were reported to be insignificant. Given that gait problems can be resistant to levodopa and directly affect the quality of life in PD, this review is timely because transcranial magnetic stimulation is increasingly implicated in a growing list of neurologic disorders.
- Full-Text
- Preview
